Eosinophilic gastroenteritis is a rare inflammatory condition in which a type of white blood cell called an eosinophil builds up in the walls of the stomach, small intestine, or both, causing symptoms that range from chronic belly pain to intestinal obstruction. The condition affects roughly 8 out of every 100,000 people and is frequently misdiagnosed because its symptoms mimic many other gastrointestinal disorders.1PubMed Central. Prevalence of eosinophilic gastritis, gastroenteritis, and colitis: Estimates from a national administrative database What makes it especially tricky is that the specific layer of the gut wall involved determines the symptoms a person experiences, so two people with the same diagnosis can look very different clinically.
What Eosinophils Are Doing in the Gut Wall
Eosinophils are immune cells that normally show up in small numbers throughout the digestive tract. They play a role in fighting parasites and modulating certain immune responses. In eosinophilic gastroenteritis, however, these cells accumulate far beyond normal levels and begin damaging the tissue they are supposed to protect. The infiltration tends to concentrate in the stomach and small intestine, though it can extend to other parts of the digestive tract.
Research has shown that eosinophils in affected tissue release cytokines, including interleukin-5 and granulocyte-macrophage colony-stimulating factor, that may perpetuate their own recruitment in a self-sustaining cycle.2PubMed. Interleukin 3, granulocyte-macrophage colony-stimulating factor, and interleukin 5 in eosinophilic gastroenteritis In plain terms, the eosinophils that arrive send chemical signals that attract more eosinophils, which send more signals, and so on. This feedback loop helps explain why the disease tends to persist and flare rather than resolve on its own.
The condition is generally considered an allergic or immune-mediated disorder. Many patients have coexisting allergies, asthma, or elevated IgE levels. Food allergens appear to be a dominant trigger, since removing food proteins from the diet can put the disease into remission.3PubMed Central. Prospective study of an amino acid-based elemental diet in an eosinophilic gastritis and gastroenteritis nutrition trial Environmental allergens like pollen and indoor allergens have also been implicated in a subset of patients, particularly those with eosinophilic esophagitis, a related condition.4PubMed Central. Food allergy and eosinophilic gastrointestinal disorders
Three Subtypes, Three Different Pictures
The gut wall has layers, and which layer the eosinophils invade determines the clinical presentation. The long-standing classification system divides eosinophilic gastroenteritis into mucosal, muscular, and serosal subtypes.5PubMed Central. Eosinophilic gastroenteritis: Approach to diagnosis and management In one study of 40 patients, 23 had predominantly mucosal disease, 12 had muscular involvement, and five had serosal disease.6Gut. Eosinophilic gastroenteritis: a clinicopathological study of patients with disease of the mucosa, muscle layer, and subserosal tissues
- Mucosal: The most common form. Eosinophils concentrate in the innermost lining of the gut. Symptoms tend to include abdominal pain, nausea, diarrhea, and, over time, malabsorption of nutrients, iron-deficiency anemia, and protein loss. Because the inner lining is where nutrients are absorbed, mucosal disease can quietly cause weight loss and nutritional deficiencies.
- Muscular: Eosinophils infiltrate the muscle layer that propels food through the intestines. This can cause the bowel wall to thicken and stiffen, leading to cramping, vomiting, and in severe cases, partial or complete bowel obstruction.
- Serosal: The rarest form, affecting the outermost layer. Patients with serosal disease tend to present with bloating, abdominal distension, and eosinophil-rich fluid in the abdominal cavity (ascites). They also tend to have higher eosinophil counts in the blood. The good news is that serosal disease usually responds dramatically to steroid treatment.7Gut. Eosinophilic gastroenteritis: a clinicopathological study of patients with disease of the mucosa, muscle layer, and subserosal tissues
In rare cases, more than one layer is involved simultaneously, which produces a confusing mix of symptoms and makes the condition even harder to pin down.8PubMed Central. Eosinophilic Gastroenteritis With Malabsorption, Acute Intestinal Obstruction, Ascites and Pleural Effusion: A Case Report and Review of Literature The variable organ location and variable depth of infiltration are the main reasons the condition produces such a wide range of symptoms from patient to patient.9PubMed. Eosinophilic gastroenteritis
Who Gets It and How Often
A national administrative database study in the United States estimated the prevalence of eosinophilic gastroenteritis at about 8.4 per 100,000 people. Eosinophilic gastritis was slightly less common at 6.3 per 100,000, and eosinophilic colitis was rarer still at 3.3 per 100,000.10PubMed Central. Prevalence of eosinophilic gastritis, gastroenteritis, and colitis: Estimates from a national administrative database These numbers likely undercount the true burden because many cases go undiagnosed or get mislabeled as irritable bowel syndrome, food intolerance, or functional dyspepsia.
There are age patterns worth noting. Eosinophilic gastroenteritis is most prevalent among children under five, while eosinophilic gastritis tends to be more common in older age groups.11PubMed Central. Prevalence of eosinophilic gastritis, gastroenteritis, and colitis: Estimates from a national administrative database The condition can appear at any age, though, and adults in their 30s through 50s make up a substantial share of diagnosed cases. A personal or family history of allergic diseases like asthma, eczema, or food allergy is common among patients.
How the Diagnosis Is Made
There is no single blood test or imaging scan that confirms eosinophilic gastroenteritis, which is one reason it carries a high rate of delayed diagnosis or misdiagnosis. The gold standard remains tissue biopsy obtained during endoscopy. A pathologist looks at the sample under a microscope and counts eosinophils per high-power field. Research suggests that a threshold of about 20 eosinophils per high-power field in the stomach or 30 in the duodenum identifies the disease with high specificity.12PubMed Central. Mast Cell and Eosinophil Counts in Gastric and Duodenal Biopsy Specimens From Patients With and Without Eosinophilic Gastroenteritis
The catch is that eosinophil infiltration can be patchy, meaning one biopsy site might look normal while another a few centimeters away is packed with eosinophils. Doctors typically take multiple biopsies from different sites to reduce the chance of a false negative. For muscular and serosal subtypes, standard endoscopic biopsies may not reach deep enough, and diagnosis sometimes requires full-thickness surgical biopsies or comes as an incidental finding during surgery for a complication like bowel obstruction.
Blood tests provide supporting clues but are not definitive on their own. Peripheral eosinophil counts in the blood are elevated in many but not all patients. One pediatric study found elevated blood eosinophils in about 71% of cases.13PubMed. Clinical features and treatment responses of children with eosinophilic gastroenteritis Research has found that the peripheral eosinophil count correlates with eosinophil counts in the stomach and duodenum, and that blood IgE levels also correlate with tissue eosinophil density in the esophagus, stomach, and duodenum.14European Journal of Gastroenterology & Hepatology. Exploration of useful clinical laboratory values as diagnostic criteria for eosinophilic gastroenteritis Proteins released by activated eosinophils, such as eosinophil cationic protein and eosinophil protein X, can be measured in stool and serum and tend to be highest in patients with active disease.15PubMed. Immunnohistological assessment of intestinal eosinophil activation in patients with eosinophilic gastroenteritis and inflammatory bowel disease These markers may eventually help track disease activity without repeated endoscopies, though they are not yet part of routine clinical practice.
Ruling Out Other Causes
Before diagnosing eosinophilic gastroenteritis, clinicians need to exclude other conditions that also cause eosinophils to accumulate in the gut. Parasitic infections are a classic mimic, since eosinophils are part of the body’s anti-parasite defense, and a heavy worm infection can produce the same tissue picture. Stool tests and a careful travel and exposure history are part of the workup. Inflammatory bowel disease (Crohn’s disease and ulcerative colitis) can sometimes feature elevated eosinophils, though the overall pattern under the microscope usually looks different. Drug reactions, certain cancers (particularly lymphomas), and connective tissue disorders all need to be considered.
The overlap with functional gastrointestinal disorders is where many patients fall through the cracks. A person with chronic belly pain, nausea, and normal-looking imaging might receive a diagnosis of irritable bowel syndrome and never undergo the endoscopy with biopsies that would reveal the eosinophilic infiltration. This is especially common with mucosal-predominant disease, where the gut lining may look grossly normal or only mildly inflamed during endoscopy, and the diagnosis depends entirely on counting eosinophils in the biopsy tissue.
Treatment With Steroids and Diet
Systemic corticosteroids, typically prednisone, have been the standard first-line treatment for decades. Most patients respond within a couple of weeks, and the serosal subtype in particular tends to respond dramatically.16Gut. Eosinophilic gastroenteritis: a clinicopathological study of patients with disease of the mucosa, muscle layer, and subserosal tissues The problem is that eosinophilic gastroenteritis is chronic, and many patients relapse when steroids are tapered. Long-term steroid use comes with well-known side effects including bone thinning, weight gain, elevated blood sugar, and immune suppression.
Budesonide, a corticosteroid that acts more locally in the gut and has fewer systemic side effects, has shown promise as an alternative. A retrospective study in children found that budesonide combined with dietary elimination produced similar histological improvement to prednisone combined with dietary elimination, with roughly 86% of patients in both groups achieving a histological response, compared to only 30% with dietary elimination alone.17Pediatric Research. Retrospective study of budesonide in children with eosinophilic gastroenteritis This result is encouraging because budesonide is generally better tolerated for longer courses.
On the dietary side, the logic is straightforward: if food allergens drive the inflammation, removing them should calm it down. A prospective trial of an amino acid-based elemental diet, which contains no intact food proteins, found that all fifteen participants who completed the six-week intervention achieved complete histological remission in both the stomach and duodenum. Symptoms, endoscopic findings, and even depression and fatigue scores all improved. When food was reintroduced, those improvements reversed, reinforcing the link between food antigens and disease activity.18PubMed Central. Prospective study of an amino acid-based elemental diet in an eosinophilic gastritis and gastroenteritis nutrition trial
The limitation is that elemental diets are expensive, taste unpleasant, and are difficult to sustain for long periods. They are more often used as a diagnostic and induction tool to prove the disease is food-driven, after which a stepwise food reintroduction process tries to identify the specific trigger foods. Empiric elimination diets that remove the most common allergens (milk, wheat, egg, soy, nuts, and seafood) are sometimes tried as a middle ground, borrowing from protocols developed for eosinophilic esophagitis, though data specific to eosinophilic gastroenteritis are limited.
Biologic Therapies on the Horizon
The emerging class of treatments generating the most interest is biologic drugs that target specific immune pathways. In eosinophilic esophagitis, dupilumab (which blocks the IL-4 receptor) has been approved and shown effects on both eosinophil counts and symptoms. Cendakimab, which targets IL-13, has also shown promise.19PubMed Central. Biologics in eosinophilic gastrointestinal diseases For non-esophageal disease, the picture is more complicated. Drugs targeting IL-5, such as mepolizumab and reslizumab, effectively reduce eosinophil counts in the tissue but have not consistently improved symptoms.20PubMed Central. Biologics in eosinophilic gastrointestinal diseases This disconnect raises the uncomfortable possibility that eosinophils, while clearly present in excess, may not be the sole drivers of symptoms.
A small study of patients with eosinophilic gastroenteritis and co-occurring asthma found that benralizumab, another IL-5-pathway biologic, improved abdominal symptoms in three of four cases and allowed some patients to stop steroids entirely.21PubMed Central. Effect of Biologics against Interleukin-5 Administered to Patients with Eosinophilic Gastroenteritis The numbers here are tiny, though, and it is too early to draw firm conclusions. Larger trials are underway to evaluate several of these biologics specifically for eosinophilic gastroenteritis and eosinophilic gastritis, which should clarify their role in the next few years.
When Surgery Becomes Necessary
Most patients never need surgery, but the muscular subtype can occasionally produce a genuine emergency. When eosinophilic infiltration thickens the bowel wall enough to narrow or block the intestinal passage, the result is a mechanical bowel obstruction, which can cause severe pain, vomiting, inability to pass gas or stool, and, if untreated, bowel perforation. In one reported case, a patient required emergency surgery for peritonitis caused by intestinal obstruction, and the resected segment of small bowel showed dense eosinophilic infiltration through the entire thickness of the wall.22PubMed Central. Eosinophilic gastroenteritis presenting as small bowel obstruction: a case report and review of the literature
Surgical cases are uncommon and typically happen when the condition has not been recognized. Once diagnosed and treated medically, recurrent obstruction is unusual. The takeaway is that persistent, unexplained obstructive symptoms, especially in someone with a history of allergies or elevated eosinophil counts, should prompt consideration of eosinophilic gastroenteritis as a possible cause.
Eosinophilic Gastroenteritis in Children
The disease has some distinct features in pediatric patients. Young children may present with nonspecific symptoms like fussiness, feeding refusal, and failure to gain weight, making the diagnosis even more elusive than in adults. In one series of 14 children, the most common initial symptoms were abdominal pain (43%) and anemia (36%), followed by low albumin, recurrent vomiting, bloody stool, and growth failure.23PubMed. Clinical features and treatment responses of children with eosinophilic gastroenteritis
Growth impairment deserves special attention. Chronic inflammation and malabsorption from mucosal-predominant disease can slow linear growth and delay puberty.24PubMed Central. Preliminary evidence in treatment of eosinophilic gastroenteritis in children: A case series Case reports have documented children with significant short stature whose growth improved after treatment for the underlying eosinophilic disease. In one report, a four-and-a-half-year-old boy presented with a height well below normal, severe anemia, and very high IgE levels; a literature review of similar pediatric cases found that short stature improved after treatment in three of four cases.25Journal of Pediatric Advance Research. Short Stature and Anemia in Pediatric Eosinophilic Gastroenteritis For pediatricians, a child with unexplained short stature, elevated eosinophils, and allergic features warrants consideration of this diagnosis.
Treatment in children follows similar principles as in adults. One pediatric case series found that children with relatively lower eosinophil infiltration responded well to initial drug treatment and did not relapse, while those with heavier infiltration were more likely to relapse and needed budesonide or methylprednisolone to achieve sustained remission.26PubMed Central. Preliminary evidence in treatment of eosinophilic gastroenteritis in children: A case series Montelukast, a leukotriene receptor antagonist commonly used for asthma, has been used as add-on therapy in children, though data on its effectiveness in this context are limited.
Living With the Condition
The physical symptoms of eosinophilic gastroenteritis are disruptive enough, but the psychological and social toll is often underappreciated. A qualitative study of adults with eosinophilic gastritis and gastroenteritis found that all participants described negative emotional impacts on their daily lives. While many experienced relief at finally receiving a correct diagnosis, the ongoing reality of managing the disease took a heavy toll. About 71% were following some form of elimination diet or elemental diet, and all participants had strong emotions related to food, including anxiety about accidental exposure to trigger foods, feeling overwhelmed by constant meal planning, and sadness over losing favorite foods.27PubMed Central. Impact on Health-Related Quality of Life in Adults with Eosinophilic Gastritis and Gastroenteritis: A Qualitative Assessment
Researchers have been working to develop validated quality-of-life scales specific to eosinophilic gastritis and gastroenteritis, recognizing that generic gastrointestinal quality-of-life tools do not capture the full experience. Early validation work on one such scale found moderate to large correlations between the disease-specific measure and psychological symptoms, fatigue, sleep disruption, and symptom severity.28PubMed Central. Initial Validation of the Eosinophilic Gastritis and Gastroenteritis Quality of Life Scale Having a validated measure matters because it gives clinical trials a way to quantify whether a treatment actually makes patients feel better in their daily lives, not just whether it reduces eosinophil counts on a biopsy slide.
Evolving Nomenclature and Where It Fits Among Related Conditions
Eosinophilic gastroenteritis belongs to a broader family of eosinophilic gastrointestinal diseases, and the way these conditions are named and classified has been shifting. Under a 2022 international consensus framework, the recommended approach is to name each condition by its specific anatomical location: eosinophilic esophagitis for the esophagus, eosinophilic gastritis for the stomach, eosinophilic enteritis for the small intestine, and eosinophilic colitis for the colon.29Human Pathology Reports. Non-esophageal eosinophilic gastrointestinal disorders A second tier of classification adds more detail about the pattern and extent of involvement.30PubMed Central. Eosinophilic Gastrointestinal Diseases Beyond the Esophagus: An Evolving Field and Nomenclature
The term “eosinophilic gastroenteritis” itself refers to disease involving both the stomach and the small intestine, and you will still encounter it widely in medical literature and patient communities. But as the field matures, you may increasingly see the more site-specific terms used by specialists. Eosinophilic esophagitis is by far the best-studied of the group, with approved therapies and established diagnostic criteria. The non-esophageal forms, including eosinophilic gastroenteritis, lag behind in terms of large clinical trials and treatment consensus. This gap is beginning to close, with several biologic drug trials and dietary intervention studies specifically targeting gastric and intestinal disease now under way. For patients, the practical implication is that while treatment options are growing, much of the management still relies on approaches adapted from eosinophilic esophagitis or from small case series rather than from large, definitive trials.